Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)

Novartis Investigative Site, Vienna

Novartis Investigative Site, Leuven

Novartis Investigative Site, La Rioja

Novartis Investigative Site, Taipei

Novartis Investigative Site, Gyeonggi-do

Novartis Investigative Site, Berlin

Novartis Investigative Site, Marseille

Novartis Investigative Site, Bundang Gu

Novartis Investigative Site, Marseille

Novartis Investigative Site, Mexico City

Novartis Investigative Site, A Coruña

Andrew and Patel Associates, Camp Hill

Lehigh Valley Health Network SC, Allentown

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Monza

Novartis Investigative Site, Dijon

Novartis Investigative Site, Brescia

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Hanover

Novartis Investigative Site, Oviedo

Novartis Investigative Site, Taoyuan District

H Lee Moffitt Cancer Center and Research Institute ., Tampa

Novartis Investigative Site, Rennes

Novartis Investigative Site, Göttingen

Novartis Investigative Site, Verona

Novartis Investigative Site, La Tronche

Novartis Investigative Site, Bologna

Novartis Investigative Site, Seville

Novartis Investigative Site, Modena

Novartis Investigative Site, Meldola

VA Ann Arbor Health System VA Ann Arbor Health System, Ann Arbor

Novartis Investigative Site, Florence

Novartis Investigative Site, Cologne

University of Iowa Hospitals and Clinics SC-3, Iowa City

Novartis Investigative Site, Ramat Gan

Mayo Clinic Rochester ., Rochester

Novartis Investigative Site, Lille

Novartis Investigative Site, Frankfurt

Novartis Investigative Site, Clermont-Ferrand

Novartis Investigative Site, Homburg

Novartis Investigative Site, Strasbourg

Novartis Investigative Site, Heidelberg

Novartis Investigative Site, Pierre-Bénite

Novartis Investigative Site, Tübingen

Novartis Investigative Site, Paris

Mays Cancer Ctr Uthsa Mdacc SC-5, San Antonio

Novartis Investigative Site, Napoli

Novartis Investigative Site, München

Novartis Investigative Site, Kaohsiung City

University of Utah / Huntsman Cancer Institute Oncology, Salt Lake City

Novartis Investigative Site, Catanzaro

Novartis Investigative Site, Ravensburg

Novartis Investigative Site, Ulm

University Of California Los Angeles Dept of Onc, Los Angeles

Novartis Investigative Site, Nuremberg

Pacific Shores Medical Group SC, Long Beach

University of California Irvine Medical Center Chao Family Chao Family Comp Cancer Center, Orange

Novartis Investigative Site, Catania

Oregon Health and Science University SC, Portland

Novartis Investigative Site, Moscow

Novartis Investigative Site, Singapore

Novartis Investigative Site, El Achrafiyé

Novartis Investigative Site, Singapore

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Tambov

Novartis Investigative Site, Tel Aviv

Massachusetts General Hospital MGH Cancer Center, Boston

Novartis Investigative Site, CABA

Novartis Investigative Site, Buenos Aires

Novartis Investigative Site, Halle

Novartis Investigative Site, Roma

Novartis Investigative Site, Nagoya

Novartis Investigative Site, Nagoya

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Akashi

Novartis Investigative Site, Sendai

Novartis Investigative Site, Okayama

Novartis Investigative Site, Ōsaka-sayama

Novartis Investigative Site, Chuo Ku

Novartis Investigative Site, Koto Ku

Novartis Investigative Site, Ube

Novartis Investigative Site, Amsterdam

Novartis Investigative Site, Groningen

Novartis Investigative Site, Maastricht

Novartis Investigative Site, Rotterdam

Novartis Investigative Site, Oslo

Novartis Investigative Site, Seoul

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Stockholm

Novartis Investigative Site, Birmingham

Novartis Investigative Site, London